Mary Quiceno

Mary Quiceno is an accomplished professional in the field of neuroscience clinical research, currently serving as Vice President at Prothena Corporation since September 2023, where roles also include Interim Head of the Neuroscience Therapeutic Area and Senior Medical Director. Prior to this position, Mary held the title of Medical Director at The Janssen Pharmaceutical Companies of Johnson & Johnson from September 2020 to August 2023 and served as Medical Director at Parexel from March 2019 to September 2020. Additionally, Mary was an Associate Professor of Neurology at the University of North Texas Health Science Center School of Public Health from March 2018 to March 2019. Mary obtained a Doctor of Medicine degree in Neurology from The University of Texas Southwestern Medical School and also holds a Doctor of Medicine degree from the University of Miami Miller School of Medicine.